Literature DB >> 33658179

Overview of Various Components of the Science of Patient Input: Advancing the Use of Patient-Reported, Real-World Evidence for Medical Device Evaluation of Innovative Products for the Treatment of Kidney Failure Using Strategically Coordinated Registry Networks.

Murray Sheldon1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33658179      PMCID: PMC8092072          DOI: 10.2215/CJN.11760720

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  6 in total

1.  Patient views about treatment of stage 5 CKD: a qualitative analysis of semistructured interviews.

Authors:  Rachael L Morton; Jeannie Devitt; Kirsten Howard; Kate Anderson; Paul Snelling; Alan Cass
Journal:  Am J Kidney Dis       Date:  2010-02-08       Impact factor: 8.860

2.  End-of-life care preferences and needs: perceptions of patients with chronic kidney disease.

Authors:  Sara N Davison
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-14       Impact factor: 8.237

3.  Incorporating Patient Preferences via Bayesian Decision Analysis.

Authors:  Shomesh E Chaudhuri; Andrew W Lo
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-03       Impact factor: 8.237

4.  Legitimization and Incorporation of Patient Preferences: The Arrow that Hit the Achilles Heel of Status Quo Kidney Care.

Authors:  Paul T Conway; Richard Knight
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-03       Impact factor: 8.237

5.  Integrating Patient Perspectives into Medical Device Regulatory Decision Making to Advance Innovation in Kidney Disease.

Authors:  Michelle E Tarver; Carolyn Neuland
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-03       Impact factor: 8.237

6.  Using Patient Preference Information to Inform Regulatory Decision Making: An Opportunity to Spur Patient-Centered Innovation in Kidney Replacement Therapy Devices.

Authors:  Jennifer E Flythe; Melissa West
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-03       Impact factor: 8.237

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.